Efficacy of daratumumab in the treatment of multiple myeloma with high-risk cytogenetics: Meta-analysis of randomized phase III trials.
暂无分享,去创建一个
M. Dimopoulos | B. Djulbegovic | P. Moreau | T. Facon | M. Mateos | S. Usmani | A. Grimshaw | L. Costa | S. Giri | S. Bal | K. Godby | P. Kharel